A Phase III, Randomized, Multi-center Study to Determine the Efficacy of the Intercalating Combination Treatment of Chemotherapy and Gefitinib or Chemotherapy as Adjuvant Treatment in NSCLC With Common EGFR Mutations.
Clinical trial NCT03381066 · UNKNOWN
Trial details
- NCT number
- NCT03381066
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2022-12-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.